Epizyme (EPZM) Plans to Sell 4.29M Common in IPO

May 13, 2013 2:14 PM EDT
Epizyme (Nasdaq: EPZM) filed an amended registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of its Common Stock. The company plans to offer 4,285,000 shares, but has not set an expected price range. The company plans to list on the The Nasdaq Global Market under the symbol "EPZM."

The offering will be made through Citigroup, Cowen and Company, Leerink Swann, JMP Securities, and Wedbush PacGrow Life Sciences.

Epizyme is a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative personalized therapeutics for patients with genetically defined cancers.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

Citi, JMP Securities, Cowen & Co

Add Your Comment